Lingohr Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-8,812
Closed -$1.5M 109
2018
Q1
$1.5M Hold
8,812
0.94% 40
2017
Q4
$1.53M Buy
8,812
+1,200
+16% +$212K 0.81% 38
2017
Q3
$1.33M Sell
7,612
-553
-7% -$98K 0.68% 49
2017
Q2
$1.34M Buy
8,165
+3,400
+71% +$553K 0.78% 57
2017
Q1
$782K Sell
4,765
-3,800
-44% -$631K 0.43% 87
2016
Q4
$1.25M Buy
8,565
+1,000
+13% +$151K 0.77% 53
2016
Q3
$1.26M Buy
+7,565
New +$1.28M 1.14% 43

Other funds holding AMGN

Lingohr Asset Management's AMGN Position: Q2 2018 in Review

Lingohr Asset Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 8,812 shares — an estimated $1.5M sold.

Lingohr Asset Management first reported a position in AMGN in Q3 2016 and held it in 7 quarters. The position peaked at $1.53M in Q4 2017. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Lingohr Asset Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Lingohr Asset Management sold 8,812 Amgen shares in Q2 2018, an estimated $1.5M.
  • Lingohr Asset Management first reported a position in Amgen in Q3 2016 and held it in 7 quarters.
  • Lingohr Asset Management's Amgen position peaked at $1.53M in Q4 2017.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Lingohr Asset Management's 13F filing for Q2 2018, filed 15 Aug 2018.